Martha Pavlakis, MD
Enriched profileProgram Director for Solid Organ Transplantation and Medical Director of Kidney and Pancreas Transplantation; Associate Professor, Harvard Medical School · Beth Israel Deaconess Medical Center
Martha Pavlakis is Program Director for Solid Organ Transplantation and Medical Director of Kidney and Pancreas Transplantation; Associate Professor, Harvard Medical School at Beth Israel Deaconess Medical Center. OpenAlex indexes 200 publications with 4,759 citations (h-index 36); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 9 Oct 2026
Overview
Updated 14 Oct 2026
Martha Pavlakis, MD, is Program Director for Solid Organ Transplantation and Medical Director of Kidney and Pancreas Transplantation at Beth Israel Deaconess Medical Center. The public record shows 200 publications with 4,759 citations (h-index 36), centered on Renal Transplantation Outcomes and Treatments, Organ Donation and Transplantation, Transplantation: Methods and Outcomes. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2004–2008).
- Most recent indexed publication: 2026 · Journal of racial and ethnic health disparities
- Top research focus: Renal Transplantation Outcomes and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 92.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
Sponsor: Beth Israel Deaconess Medical Center
- House Calls and Decision Support: Improving Access to Live Donor Transplantation
Sponsor: Beth Israel Deaconess Medical Center
- A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
Sponsor: Beth Israel Deaconess Medical Center
Industry payments
Updated 14 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202510 payments$14,574openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20247 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
30.5%Beta blocker11.1%Metoprolol Succinate35%Carvedilol35%Labetalol Hcl20%Metoprolol Tartrate10%Part D<11 patientsAngiotensin receptor blocker (ARB)5.5%Losartan Potassium100%Part D≥14 patients+ 5 more classes in this area
Metabolism & gastrointestinal
29.9%Corticosteroid21.7%Prednisone100%Part D≥53 patientsProton pump inhibitor5%Omeprazole58%Pantoprazole Sodium42%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
18%Calcineurin inhibitor14.9%Tacrolimus93%Envarsus Xr7%Part D<11 patientsKinase inhibitor1.8%Sirolimus100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2004–2008 per NIH RePORTER. The latest:
- CLINICAL TRIAL: RITUXIMAB IN RENAL ALLOGRAFT RECIPIENTS WITH EARLY ANTI-HLA ALLO
Beth Israel Deaconess Medical Center
FY2008$703M01RR001032 - RITUXIMAB IN RENAL ALLOGRAFT RECIPIENTS WITH EARLY ANTI-HLA ALLOANTIBODIES
Beth Israel Deaconess Medical Center
FY2007$5,283M01RR001032 - ISLET TRANSPLANTATION IN TYPE I DIABETIC REICIPIENTS OF RENAL ALLOGRAFT USING TH
Beth Israel Deaconess Medical Center
FY2007$4,107M01RR001032
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Transplant House Calls Plus Peer Mentorship: Assessing Impact on Living Donor Kidney Transplant Access and Patient-Reported Outcomes for Black Patients.
Journal of racial and ethnic health disparities
Article2026 - Impact of Cold Ischemia Time and Donor Age on Donation After Circulatory Death Kidney Transplant Outcomes: A UNOS Mate-Kidney Analysis.
Clinical transplantation
Article2024 - A Restorative Justice Project in Kidney Allocation-The Wait Time Modification for Black and African American Candidates Affected by the Race-Based eGFR Equation.
Journal of the American Society of Nephrology
Article2023 - Comprehensive review: Frailty in pancreas transplant candidates and recipients.
Clinical transplantation
Review2023
Most-cited works
by citation count (OpenAlex)- 01
- 02The Medical Evaluation of Living Kidney Donors: A Survey of US Transplant CentersArticle288 citations2007
- 03Donor Kidney ExchangesArticle158 citations2004
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
SUNY at Buffalo
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Editorial & leadership roles
journal and society appointments- Contributor to committees and national initiatives
American Society of Transplantation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kidney.org ↗ - Contributor to committees and national initiatives
Organ Procurement and Transplantation Network (OPTN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kidney.org ↗
Awards & honors
honors on the public record- Excellence in Kidney Transplantation Award
National Kidney Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine